DAMARIS IRIONDO: Open Payments
NPI 1821756982 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 24 payments from 15 companies in 2025. Trend: 2023 $4,749 · 2024 $731 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $110 |
| GENZYME CORPORATION | 2 | $60 |
| Journey Medical Corporation | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $43 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $38 |
| ABBVIE INC. | 2 | $37 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $24 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $23 |
Products named: Winlevi, DUPIXENT, ILUMYA, NEMLUVIO, Cabtreo, Rhapsido, Neo-Synalar, Fraxel.
Industry payments across TX — which companies pay providers there.
